Altria Q4 EPS In-Line but Revenue Misses, Where is the Growth? Scott Willis·January 30, 2020Altria (NYSE: MO) is sporting a juicy dividend rate, but recent write-offs on the JUUL investment are a...Investing·0 Comments·
Cronos Q4 2018 Earnings Review – The New Most Expensive Stock in Cannabis Scott Willis·March 26, 2019In Cronos' (TSX: CRON) latest earnings report, they both grabbed the crown for most expensive cannabis company and disappointed with operations. Impressive.Marijuana Analysis·1 Comment·
Altria Invests $2.4 Billion in Cronos Group Ty Arthur·March 8, 2019Altria Group, Inc. (NYSE: MO) today acquired 45% of cannabis company Cronos Group Inc. (NASDAQ: CRON; TSX: CRON)...Marijuana News·1 Comment·
Aphria – Let the Bidding Begin Scott Willis·December 28, 2018The hostile bid for Aphria has put consumer goods companies on notice. Invest now or lose out on...Marijuana Analysis·2 Comments·
All Time Highs (Episode 5) The Farm Bill, Altria M&A, and Aphria Editor·December 17, 2018In this episode of All Time Highs, Thomas George discusses the Farm Bill opening the door to CBD...Marijuana News·1 Comment·
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (October 13, 2018) Scott Willis·October 13, 2018Altria may be circling Aphria. Medmen does a transformative deal, Review of Aphria earnings and more......Marijuana News·0 Comments·
Altria has Aphria in their Crosshairs – What a Deal Would Mean for the Cannabis Industry Scott Willis·October 11, 2018Altria is rumoured to be seeking a direct minority stake in Aphria, we look at potential for such...Marijuana Analysis·0 Comments·
